NBS-nytt
15.02.2017
The 21st European Symposium on Quantitative Structure-Activity Relationship (EuroQSAR) took place from the 4th to 8th of September in Verona, the city of Romeo and Juliet. Owing to the NBS supporting I was able to join this interesting conference.
The pioneers of QSAR were Corwin Hansch and Toshio Fujita in the early 1960s. QSAR describes the relationship of the chemical structure of a molecule with its pharmacological, chemical, biological or physical effects. The first QSAR symposium in Europe took place in 1973. In the course of time EuroQSAR became the most important symposium for computational drug design and pharmacoinfomatics in Europe. The 21st symposium was divided into 10 sessions. Each of these sessions consisted of a plenary lecture, keynote lectures and oral communications. In addition, 257 posters were presented in two sessions. To ensure that there was opportunity for interaction between participants and exhibiting companies, coffee breaks and social activities were also included in the programme.
The subtitle of the symposium was "Where Molecular Simulations Meet Drug Discovery". Thus, there was a special focus set on molecular dynamics and other approaches related to drug design and discovery. However, emphasis was also given to big data analytics and precision medicine as well as ligand-based and structure
Gå til medietThe subtitle of the symposium was "Where Molecular Simulations Meet Drug Discovery". Thus, there was a special focus set on molecular dynamics and other approaches related to drug design and discovery. However, emphasis was also given to big data analytics and precision medicine as well as ligand-based and structure